Plasmodium falciparum Plasmepsin 2 Duplications, West Africa

Dihydroartemisinin/piperaquine (DHA/PPQ) is increasingly deployed as an antimalaria drug in Africa. We report the detection in Mali of Plasmodium falciparum infections carrying plasmepsin 2 duplications (associated with piperaquine resistance) in 7/65 recurrent infections within 2 months after DHA/P...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Juliana Inoue, Miguel Silva, Bakary Fofana, Kassim Sanogo, Andreas Mårtensson, Issaka Sagara, Anders Björkman, Maria Isabel Veiga, Pedro Eduardo Ferreira, Abdoulaye Djimde, José Pedro Gil
स्वरूप: लेख
भाषा:English
प्रकाशित: Centers for Disease Control and Prevention 2018-08-01
श्रृंखला:Emerging Infectious Diseases
विषय:
ऑनलाइन पहुंच:https://wwwnc.cdc.gov/eid/article/24/8/18-0370_article
_version_ 1828462010086457344
author Juliana Inoue
Miguel Silva
Bakary Fofana
Kassim Sanogo
Andreas Mårtensson
Issaka Sagara
Anders Björkman
Maria Isabel Veiga
Pedro Eduardo Ferreira
Abdoulaye Djimde
José Pedro Gil
author_facet Juliana Inoue
Miguel Silva
Bakary Fofana
Kassim Sanogo
Andreas Mårtensson
Issaka Sagara
Anders Björkman
Maria Isabel Veiga
Pedro Eduardo Ferreira
Abdoulaye Djimde
José Pedro Gil
author_sort Juliana Inoue
collection DOAJ
description Dihydroartemisinin/piperaquine (DHA/PPQ) is increasingly deployed as an antimalaria drug in Africa. We report the detection in Mali of Plasmodium falciparum infections carrying plasmepsin 2 duplications (associated with piperaquine resistance) in 7/65 recurrent infections within 2 months after DHA/PPQ treatment. These findings raise concerns about the long-term efficacy of DHA/PPQ treatment in Africa.
first_indexed 2024-12-11T02:28:37Z
format Article
id doaj.art-e2dc94e09a1f4a84960d1e3a39202c7c
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-12-11T02:28:37Z
publishDate 2018-08-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-e2dc94e09a1f4a84960d1e3a39202c7c2022-12-22T01:23:53ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592018-08-012481591159310.3201/eid2408.180370Plasmodium falciparum Plasmepsin 2 Duplications, West AfricaJuliana InoueMiguel SilvaBakary FofanaKassim SanogoAndreas MårtenssonIssaka SagaraAnders BjörkmanMaria Isabel VeigaPedro Eduardo FerreiraAbdoulaye DjimdeJosé Pedro GilDihydroartemisinin/piperaquine (DHA/PPQ) is increasingly deployed as an antimalaria drug in Africa. We report the detection in Mali of Plasmodium falciparum infections carrying plasmepsin 2 duplications (associated with piperaquine resistance) in 7/65 recurrent infections within 2 months after DHA/PPQ treatment. These findings raise concerns about the long-term efficacy of DHA/PPQ treatment in Africa.https://wwwnc.cdc.gov/eid/article/24/8/18-0370_articlemalariapiperaquineresistancePlasmodium falciparumplasmepsin 2Pfpm2
spellingShingle Juliana Inoue
Miguel Silva
Bakary Fofana
Kassim Sanogo
Andreas Mårtensson
Issaka Sagara
Anders Björkman
Maria Isabel Veiga
Pedro Eduardo Ferreira
Abdoulaye Djimde
José Pedro Gil
Plasmodium falciparum Plasmepsin 2 Duplications, West Africa
Emerging Infectious Diseases
malaria
piperaquine
resistance
Plasmodium falciparum
plasmepsin 2
Pfpm2
title Plasmodium falciparum Plasmepsin 2 Duplications, West Africa
title_full Plasmodium falciparum Plasmepsin 2 Duplications, West Africa
title_fullStr Plasmodium falciparum Plasmepsin 2 Duplications, West Africa
title_full_unstemmed Plasmodium falciparum Plasmepsin 2 Duplications, West Africa
title_short Plasmodium falciparum Plasmepsin 2 Duplications, West Africa
title_sort plasmodium falciparum plasmepsin 2 duplications west africa
topic malaria
piperaquine
resistance
Plasmodium falciparum
plasmepsin 2
Pfpm2
url https://wwwnc.cdc.gov/eid/article/24/8/18-0370_article
work_keys_str_mv AT julianainoue plasmodiumfalciparumplasmepsin2duplicationswestafrica
AT miguelsilva plasmodiumfalciparumplasmepsin2duplicationswestafrica
AT bakaryfofana plasmodiumfalciparumplasmepsin2duplicationswestafrica
AT kassimsanogo plasmodiumfalciparumplasmepsin2duplicationswestafrica
AT andreasmartensson plasmodiumfalciparumplasmepsin2duplicationswestafrica
AT issakasagara plasmodiumfalciparumplasmepsin2duplicationswestafrica
AT andersbjorkman plasmodiumfalciparumplasmepsin2duplicationswestafrica
AT mariaisabelveiga plasmodiumfalciparumplasmepsin2duplicationswestafrica
AT pedroeduardoferreira plasmodiumfalciparumplasmepsin2duplicationswestafrica
AT abdoulayedjimde plasmodiumfalciparumplasmepsin2duplicationswestafrica
AT josepedrogil plasmodiumfalciparumplasmepsin2duplicationswestafrica